NCT00362687 GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance Status COMPLETED Phase PHASE4
NCT00362544 PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia Status COMPLETED Phase PHASE4
NCT00353587 Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin Status COMPLETED Phase PHASE2/PHASE3
NCT00353574 DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension Status TERMINATED Phase PHASE3
NCT00352053 Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy Status COMPLETED Phase PHASE3
NCT00334412 COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis Status COMPLETED Phase PHASE4
NCT00334256 Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) Status COMPLETED Phase PHASE2
NCT00330369 DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension Status COMPLETED Phase PHASE3
NCT00326157 PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00324649 Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada Status COMPLETED Phase PHASE4
NCT00323687 SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada Status COMPLETED Phase PHASE4
NCT00323544 SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection Status COMPLETED Phase PHASE3
NCT00323492 TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada Status COMPLETED Phase PHASE4
NCT00307489 Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil Status COMPLETED Phase PHASE2
NCT00302822 Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130) Status COMPLETED Phase PHASE3
NCT00298363 Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. Status COMPLETED Phase PHASE2
NCT00298350 Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART. Status COMPLETED Phase PHASE2
NCT00285428 Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00270556 Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. Status COMPLETED Phase PHASE2